日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Differential contributions of human oligosaccharyltransferase complexes OST-A and OST-B to HIV-1 envelope glycoprotein glycosylation

人类寡糖基转移酶复合物OST-A和OST-B对HIV-1包膜糖蛋白糖基化的差异性贡献

Atabey, Tugba; Derking, Ronald; Newby, Maddy L; Bouhuijs, Joey H; Snitselaar, Jonne L; Vink, Monique; Aldon, Yoann; Allen, Joel D; Crispin, Max; Sanders, Rogier W

Computed tomography and [(18)F]-FDG PET imaging provide additional readouts for COVID-19 pathogenesis and therapies evaluation in non-human primates

计算机断层扫描和[(18)F]-FDG PET成像为非人灵长类动物COVID-19发病机制和治疗评估提供了额外的读数。

Naninck, Thibaut; Kahlaoui, Nidhal; Lemaitre, Julien; Maisonnasse, Pauline; De Mori, Antoine; Pascal, Quentin; Contreras, Vanessa; Marlin, Romain; Relouzat, Francis; Delache, Benoît; Hérate, Cécile; Aldon, Yoann; van Gils, Marit; Zabaleta, Nerea; Ho Tsong Fang, Raphaël; Bosquet, Nathalie; Sanders, Rogier W; Vandenberghe, Luk H; Chapon, Catherine; Le Grand, Roger

Immunogenicity of stabilized HIV-1 Env trimers delivered by self-amplifying mRNA.

通过自扩增 mRNA 递送的稳定 HIV-1 Env 三聚体的免疫原性

Aldon Yoann, McKay Paul F, Moreno Herrero Jorge, Vogel Annette B, Lévai Réka, Maisonnasse Pauline, Dereuddre-Bosquet Nathalie, Haas Heinrich, Fábián Katalin, Le Grand Roger, Sahin Ugur, Shattock Robin J

The entry inhibitor DS003 (BMS-599793): a BMS-806 analogue, provides superior activity as a pre-exposure prophylaxis candidate.

进入抑制剂 DS003 (BMS-599793):BMS-806 类似物,作为暴露前预防候选药物具有优异的活性

Herrera Carolina, Harman Sarah, Aldon Yoann, Rogers Paul, Armanasco Naomi, Ziprin Paul, Stieh Daniel, Nuttall Jeremy, Shattock Robin J